Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Carcinoma, Non-Small-Cell Lung"" wg kryterium: Temat


Tytuł:
A deep learning model integrating multisequence MRI to predict EGFR mutation subtype in brain metastases from non-small cell lung cancer.
Autorzy:
Li Y; Department of Radiology, Beijing Chest Hospital, Capital Medical University, Beijing, 101149, China.
Lv X; Department of Radiology, Beijing Chest Hospital, Capital Medical University, Beijing, 101149, China.
Chen C; Institute of Advanced Research, Infervision Medical Technology Co., Ltd., Beijing, 100025, China.
Yu R; Institute of Advanced Research, Infervision Medical Technology Co., Ltd., Beijing, 100025, China.
Wang B; Department of Radiology, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, 101149, China.
Wang D; Institute of Advanced Research, Infervision Medical Technology Co., Ltd., Beijing, 100025, China. .
Hou D; Department of Radiology, Beijing Chest Hospital, Capital Medical University, Beijing, 101149, China. .
Pokaż więcej
Źródło:
European radiology experimental [Eur Radiol Exp] 2024 Jan 02; Vol. 8 (1), pp. 2. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/diagnostic imaging
Carcinoma, Non-Small-Cell Lung*/genetics
Deep Learning*
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/genetics
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/genetics
Humans ; Retrospective Studies ; Magnetic Resonance Imaging ; ErbB Receptors/genetics ; Mutation
Czasopismo naukowe
Tytuł:
Targeted treatment for unresectable EGFR mutation-positive stage III non-small cell lung cancer: Emerging evidence and future perspectives.
Autorzy:
Kato T; Department of Thoracic Oncology, Kanagawa Cancer Center, Asahi Ward, Yokohama, Japan. Electronic address: .
Casarini I; Servicio Oncología, Hospital Bernardo Houssay, Mar del Plata, Buenos Aires, Argentina.
Cobo M; Unidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, IBIMA, Málaga, Spain.
Faivre-Finn C; University of Manchester and The Christie NHS Foundation Trust, Manchester, United Kingdom.
Hegi-Johnson F; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
Lu S; Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Özgüroğlu M; Department of Internal Medicine, Division of Medical Oncology, Clinical Trial Unit, Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Istanbul, Turkey.
Ramalingam SS; Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA, USA.
Pokaż więcej
Źródło:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Jan; Vol. 187, pp. 107414. Date of Electronic Publication: 2023 Nov 08.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Humans ; Retrospective Studies ; Protein Kinase Inhibitors/pharmacology ; ErbB Receptors/genetics ; Mutation/genetics
Czasopismo naukowe
Tytuł:
The interplay between autophagy and apoptosis: its implication in lung cancer and therapeutics.
Autorzy:
Biswas U; Department of Biotechnology and Dr. B. C. Guha Centre for Genetic Engineering and Biotechnology, University of Calcutta, 35 Ballygunge Circular Road, Kolkata, West Bengal, India.
Roy R; Department of Biotechnology and Dr. B. C. Guha Centre for Genetic Engineering and Biotechnology, University of Calcutta, 35 Ballygunge Circular Road, Kolkata, West Bengal, India.
Ghosh S; Department of Biotechnology and Dr. B. C. Guha Centre for Genetic Engineering and Biotechnology, University of Calcutta, 35 Ballygunge Circular Road, Kolkata, West Bengal, India.
Chakrabarti G; Department of Biotechnology and Dr. B. C. Guha Centre for Genetic Engineering and Biotechnology, University of Calcutta, 35 Ballygunge Circular Road, Kolkata, West Bengal, India. Electronic address: .
Pokaż więcej
Źródło:
Cancer letters [Cancer Lett] 2024 Mar 31; Vol. 585, pp. 216662. Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/metabolism
Humans ; Apoptosis/genetics ; Signal Transduction ; Autophagy/genetics ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
Notch signaling and targeted therapy in non-small cell lung cancer.
Autorzy:
Sun J; Xiangya School of Medicine, Central South University, Changsha, Hunan, 410013, PR China.
Dong M; Xiangya School of Medicine, Central South University, Changsha, Hunan, 410013, PR China.
Xiang X; Xiangya School of Medicine, Central South University, Changsha, Hunan, 410013, PR China.
Zhang S; Department of Cell Biology, School of Life Sciences, Central South University, Changsha, Hunan, 410013, PR China. Electronic address: .
Wen D; Department of Cell Biology, School of Life Sciences, Central South University, Changsha, Hunan, 410013, PR China. Electronic address: doudou_.
Pokaż więcej
Źródło:
Cancer letters [Cancer Lett] 2024 Mar 31; Vol. 585, pp. 216647. Date of Electronic Publication: 2024 Jan 30.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Humans ; Receptor, Notch1/metabolism ; Receptors, Notch/metabolism ; Receptor, Notch2/metabolism ; Receptor, Notch3 ; Signal Transduction
Czasopismo naukowe
Tytuł:
Fast proliferating and slowly migrating non-small cell lung cancer cells are vulnerable to decitabine and retinoic acid combinatorial treatment.
Autorzy:
Pelos G; Division of Cancer Research, Department of Thoracic Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Riester M; Division of Cancer Research, Department of Thoracic Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Pal J; Division of Cancer Research, Department of Thoracic Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Myacheva K; Division of Cancer Research, Department of Thoracic Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg, A Partnership Between DKFZ and University Medical Center Freiburg, Freiburg, Germany.
Moneke I; Division of Cancer Research, Department of Thoracic Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Rotondo JC; Department of Internal Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Lübbert M; Department of Internal Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Diederichs S; Division of Cancer Research, Department of Thoracic Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg, A Partnership Between DKFZ and University Medical Center Freiburg, Freiburg, Germany.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 15; Vol. 154 (6), pp. 1029-1042. Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/metabolism
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Humans ; Aged ; Tretinoin/pharmacology ; Tretinoin/therapeutic use ; Decitabine/pharmacology ; Decitabine/therapeutic use ; Proto-Oncogene Proteins p21(ras)/genetics ; Proto-Oncogene Proteins p21(ras)/metabolism ; Cell Line, Tumor ; Cell Proliferation
Czasopismo naukowe
Tytuł:
Impact of LKB1 status on radiation outcome in patients with stage III non-small-cell lung cancer.
Autorzy:
Sitthideatphaiboon P; Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, 1873 Henry Dunant Rd, Pathumwan, Bangkok, 10330, Thailand.
Nantavithya C; Division of Therapeutic Radiation and Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, 10330, Thailand.
Chantranuwat P; Department of Pathology, Faculty of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, 10330, Thailand.
Vinayanuwattikun C; Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, 1873 Henry Dunant Rd, Pathumwan, Bangkok, 10330, Thailand.
Sriuranpong V; Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, 1873 Henry Dunant Rd, Pathumwan, Bangkok, 10330, Thailand. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 14; Vol. 14 (1), pp. 6146. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/radiotherapy
Carcinoma, Non-Small-Cell Lung*/metabolism
Lung Neoplasms*/genetics
Lung Neoplasms*/radiotherapy
Lung Neoplasms*/metabolism
Humans ; Biomarkers ; Chemoradiotherapy ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Degradation of Polo-like Kinase 1 by the Novel Poly-Arginine N-Degron Pathway PROTAC Regulates Tumor Growth in Nonsmall Cell Lung Cancer.
Autorzy:
Gunasekaran P; Division of Magnetic Resonance, Korea Basic Science Institute (KBSI), Ochang, Chungbuk 28119, Republic of Korea.; Dandicure Inc, Ochang, Chungbuk 28119, Republic of Korea.
Hwang YS; Division of Magnetic Resonance, Korea Basic Science Institute (KBSI), Ochang, Chungbuk 28119, Republic of Korea.; Dandicure Inc, Ochang, Chungbuk 28119, Republic of Korea.
Lee GH; Dandicure Inc, Ochang, Chungbuk 28119, Republic of Korea.
Park J; College of Pharmacy, Chungbuk National University, Cheongju, Chungbuk 28160, Republic of Korea.
Kim JG; Nucleic Acid Therapeutics Research Center, Korea Research Institute of Bioscience and Biotechnology, 30 Yeongudanji-ro, Ochang, Cheongwon, Chungbuk 28116, Republic of Korea.
La YK; Division of Magnetic Resonance, Korea Basic Science Institute (KBSI), Ochang, Chungbuk 28119, Republic of Korea.
Park NY; Division of Magnetic Resonance, Korea Basic Science Institute (KBSI), Ochang, Chungbuk 28119, Republic of Korea.
Kothandaraman R; Dandicure Inc, Ochang, Chungbuk 28119, Republic of Korea.
Yim MS; Division of Vaccine Development Coordination, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju 28159, Republic of Korea.
Choi J; Division of Magnetic Resonance, Korea Basic Science Institute (KBSI), Ochang, Chungbuk 28119, Republic of Korea.
Kim HN; Division of Magnetic Resonance, Korea Basic Science Institute (KBSI), Ochang, Chungbuk 28119, Republic of Korea.
Park IY; College of Pharmacy, Chungbuk National University, Cheongju, Chungbuk 28160, Republic of Korea.
Lee SJ; College of Pharmacy, Chungbuk National University, Cheongju, Chungbuk 28160, Republic of Korea.
Kim MH; Department of Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan 49241, Republic of Korea.
Cha-Molstad H; Nucleic Acid Therapeutics Research Center, Korea Research Institute of Bioscience and Biotechnology, 30 Yeongudanji-ro, Ochang, Cheongwon, Chungbuk 28116, Republic of Korea.
Shin SY; Department of Cellular and Molecular Medicine, School of Medicine, Chosun University, Gwangju 61452, Republic of Korea.
Ryu EK; Division of Magnetic Resonance, Korea Basic Science Institute (KBSI), Ochang, Chungbuk 28119, Republic of Korea.; Department of Bio-Analytical Science, University of Science & Technology, Daejeon 34113, Republic of Korea.
Bang JK; Division of Magnetic Resonance, Korea Basic Science Institute (KBSI), Ochang, Chungbuk 28119, Republic of Korea.; Dandicure Inc, Ochang, Chungbuk 28119, Republic of Korea.; Department of Bio-Analytical Science, University of Science & Technology, Daejeon 34113, Republic of Korea.
Pokaż więcej
Źródło:
Journal of medicinal chemistry [J Med Chem] 2024 Mar 14; Vol. 67 (5), pp. 3307-3320. Date of Electronic Publication: 2023 Dec 17.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/pathology
Humans ; Animals ; Mice ; Cell Cycle Proteins ; Proteolysis Targeting Chimera ; Protein Serine-Threonine Kinases ; Polo-Like Kinase 1 ; Apoptosis ; Degrons ; Cell Line, Tumor ; G2 Phase Cell Cycle Checkpoints ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use
Czasopismo naukowe
Tytuł:
Dendritic cell-targeted therapy expands CD8 T cell responses to bona-fide neoantigens in lung tumors.
Autorzy:
López L; Cellular Immunology, International Centre for Genetic Engineering and Biotechnology, ICGEB, Trieste, Italy.
Morosi LG; Cellular Immunology, International Centre for Genetic Engineering and Biotechnology, ICGEB, Trieste, Italy.
La Terza F; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy.
Bourdely P; Université Paris Cité, Institut Cochin, INSERM 1016, Paris, France.; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, VIB, KU Leuven, Leuven, Belgium.
Rospo G; Department of Oncology, Molecular Biotechnology Center, University of Torino, Turin, Italy.; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Amadio R; Cellular Immunology, International Centre for Genetic Engineering and Biotechnology, ICGEB, Trieste, Italy.
Piperno GM; Cellular Immunology, International Centre for Genetic Engineering and Biotechnology, ICGEB, Trieste, Italy.
Russo V; G. Armenise-Harvard Immune Regulation Unit, IIGM, Candiolo, TO, Italy.; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, TO, Italy.
Volponi C; Cellular Immunology, International Centre for Genetic Engineering and Biotechnology, ICGEB, Trieste, Italy.; Cellular and Molecular Oncoimmunology, IRCCS Humanitas Research Hospital, Rozzano, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Vodret S; Cellular Immunology, International Centre for Genetic Engineering and Biotechnology, ICGEB, Trieste, Italy.
Joshi S; Cellular Immunology, International Centre for Genetic Engineering and Biotechnology, ICGEB, Trieste, Italy.
Giannese F; Center for Omics Sciences, IRCCS San Raffaele Institute, Milano, Italy.; Vita-Salute San Raffaele University, Milan, Italy.
Lazarevic D; Center for Omics Sciences, IRCCS San Raffaele Institute, Milano, Italy.; Vita-Salute San Raffaele University, Milan, Italy.
Germano G; Department of Oncology, Molecular Biotechnology Center, University of Torino, Turin, Italy.; IFOM ETS - The AIRC Institute of Molecular Oncology, 20139, Milan, Italy.
Stoitzner P; Department of Dermatology, Venereology & Allergology, Medical University of Innsbruck, Innsbruck, Austria.
Bardelli A; Department of Oncology, Molecular Biotechnology Center, University of Torino, Turin, Italy.; IFOM ETS - The AIRC Institute of Molecular Oncology, 20139, Milan, Italy.
Dalod M; Aix-Marseille University, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Turing Center for Living Systems, Marseille, France.
Pace L; G. Armenise-Harvard Immune Regulation Unit, IIGM, Candiolo, TO, Italy.; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, TO, Italy.
Caronni N; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy.
Guermonprez P; Institut Pasteur, CNRS 3738, University de Paris Cité, Paris, France.
Benvenuti F; Cellular Immunology, International Centre for Genetic Engineering and Biotechnology, ICGEB, Trieste, Italy. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2024 Mar 13; Vol. 15 (1), pp. 2280. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/therapy
Carcinoma, Non-Small-Cell Lung*/metabolism
Lung Neoplasms*/therapy
Lung Neoplasms*/metabolism
Female ; Mice ; Animals ; Dendritic Cells ; CD8-Positive T-Lymphocytes ; Cross-Priming
Czasopismo naukowe
Tytuł:
Text analysis framework for identifying mutations among non-small cell lung cancer patients from laboratory data.
Autorzy:
Yusuf A; Department of Oncology, University of Calgary, Calgary, AB, T2N 4N2, Canada.
Boyne DJ; Department of Oncology, University of Calgary, Calgary, AB, T2N 4N2, Canada.; Department of Community Health Sciences, University of Calgary, Calgary, AB, T2N 4Z6, Canada.
O'Sullivan DE; Department of Oncology, University of Calgary, Calgary, AB, T2N 4N2, Canada.; Department of Community Health Sciences, University of Calgary, Calgary, AB, T2N 4Z6, Canada.
Brenner DR; Department of Oncology, University of Calgary, Calgary, AB, T2N 4N2, Canada.; Department of Community Health Sciences, University of Calgary, Calgary, AB, T2N 4Z6, Canada.
Cheung WY; Department of Oncology, University of Calgary, Calgary, AB, T2N 4N2, Canada.; Department of Community Health Sciences, University of Calgary, Calgary, AB, T2N 4Z6, Canada.
Mirza I; Alberta Precision Laboratories, Calgary, AB, T2L 2K8, Canada.
Jarada TN; Department of Oncology, University of Calgary, Calgary, AB, T2N 4N2, Canada. .; Department of Community Health Sciences, University of Calgary, Calgary, AB, T2N 4Z6, Canada. .
Pokaż więcej
Źródło:
BMC medical research methodology [BMC Med Res Methodol] 2024 Mar 11; Vol. 24 (1), pp. 63. Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/diagnosis
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Humans ; Laboratories ; NAD ; Mutation ; Natural Language Processing ; ErbB Receptors ; Biomarkers ; Electronic Health Records
Czasopismo naukowe
Tytuł:
Integrating image and gene-data with a semi-supervised attention model for prediction of KRAS gene mutation status in non-small cell lung cancer.
Autorzy:
Xue Y; College of Information and Computer, Taiyuan University of Technology, Taiyuan, Shanxi, China.
Zhang D; College of Information and Computer, Taiyuan University of Technology, Taiyuan, Shanxi, China.
Jia L; College of Information and Computer, Taiyuan University of Technology, Taiyuan, Shanxi, China.
Yang W; College of Information and Computer, Taiyuan University of Technology, Taiyuan, Shanxi, China.
Zhao J; School of Software, Taiyuan University of Technology, Taiyuan, Shanxi, China.; College of Information, Jinzhong College of Information, Taiyuan, Shanxi, China.
Qiang Y; College of Information and Computer, Taiyuan University of Technology, Taiyuan, Shanxi, China.
Wang L; College of Information, Jinzhong College of Information, Taiyuan, Shanxi, China.
Qiao Y; First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Yue H; First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 11; Vol. 19 (3), pp. e0297331. Date of Electronic Publication: 2024 Mar 11 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/diagnostic imaging
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/genetics
Humans ; Proto-Oncogene Proteins p21(ras)/genetics ; Biopsy ; Mutation ; Image Processing, Computer-Assisted
Czasopismo naukowe
Tytuł:
Survival outcomes of targeted and immune consolidation therapies in locally advanced unresectable lung adenocarcinoma.
Autorzy:
Wang X; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, Shandong, China.
Meng X; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, Shandong, China.
Cai G; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, Shandong, China.
Jin P; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, Shandong, China.
Bai M; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, Shandong, China.
Fu Y; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, Shandong, China.
Wang Z; Department of Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Guo J; Department of Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Han X; Department of Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China. Electronic address: .
Pokaż więcej
Źródło:
International immunopharmacology [Int Immunopharmacol] 2024 Mar 10; Vol. 129, pp. 111684. Date of Electronic Publication: 2024 Feb 16.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/therapy
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/therapy
Lung Neoplasms*/drug therapy
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/therapy
Humans ; Consolidation Chemotherapy ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Tet methylcytosine dioxygenase 2 (TET2) deficiency elicits EGFR-TKI (tyrosine kinase inhibitors) resistance in non-small cell lung cancer.
Autorzy:
Zhang J; Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital of Sichuan University, Chengdu, 610097, China.; Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Sichuan University, Chengdu, 610097, China.
Zhao K; Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital of Sichuan University, Chengdu, 610097, China.; Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Sichuan University, Chengdu, 610097, China.
Zhou W; Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital of Sichuan University, Chengdu, 610097, China.; Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Sichuan University, Chengdu, 610097, China.
Kang R; Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital of Sichuan University, Chengdu, 610097, China.; Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Sichuan University, Chengdu, 610097, China.
Wei S; Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital of Sichuan University, Chengdu, 610097, China.; Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Sichuan University, Chengdu, 610097, China.
Shu Y; Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital of Sichuan University, Chengdu, 610097, China.; Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Sichuan University, Chengdu, 610097, China.
Yu C; Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital of Sichuan University, Chengdu, 610097, China.; Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Sichuan University, Chengdu, 610097, China.
Ku Y; Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital of Sichuan University, Chengdu, 610097, China.; Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Sichuan University, Chengdu, 610097, China.
Mao Y; Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital of Sichuan University, Chengdu, 610097, China.; Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Sichuan University, Chengdu, 610097, China.
Luo H; Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital of Sichuan University, Chengdu, 610097, China.; Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Sichuan University, Chengdu, 610097, China.
Yang J; Biobank of West China Hospital, Sichuan University, Chengdu, 610041, China.
Mei J; Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital of Sichuan University, Chengdu, 610097, China.
Pu Q; Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital of Sichuan University, Chengdu, 610097, China.
Deng S; Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital of Sichuan University, Chengdu, 610097, China.; Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Sichuan University, Chengdu, 610097, China.
Zha Z; Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital of Sichuan University, Chengdu, 610097, China.; Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Sichuan University, Chengdu, 610097, China.
Yuan G; Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital of Sichuan University, Chengdu, 610097, China.; Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Sichuan University, Chengdu, 610097, China.
Shen S; Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital of Sichuan University, Chengdu, 610097, China.; Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Sichuan University, Chengdu, 610097, China.
Chen Y; Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital of Sichuan University, Chengdu, 610097, China. .; Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Sichuan University, Chengdu, 610097, China. .
Liu L; Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital of Sichuan University, Chengdu, 610097, China. lunxu_.; Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Sichuan University, Chengdu, 610097, China. lunxu_.
Pokaż więcej
Źródło:
Signal transduction and targeted therapy [Signal Transduct Target Ther] 2024 Mar 09; Vol. 9 (1), pp. 65. Date of Electronic Publication: 2024 Mar 09.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/metabolism
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Dioxygenases*/genetics
Humans ; Tyrosine Kinase Inhibitors ; NF-kappa B/genetics ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Mutation ; ErbB Receptors ; DNA-Binding Proteins/genetics
Czasopismo naukowe
Tytuł:
Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases.
Autorzy:
Kahraman S; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey. .
Karakaya S; Department of Medical Oncology, Ankara Ataturk Sanatoryum Training and Research Hospital, Ankara, Turkey.
Kaplan MA; Department of Medical Oncology, Dicle University Medical Faculty Hospital, Diyarbakir, Turkey.
Goksu SS; Department of Medical Oncology, Akdeniz University Hospital, Antalya, Turkey.
Ozturk A; Department of Medical Oncology, Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul, Turkey.
Isleyen ZS; Department of Medical Oncology, Faculty of Medicine Hospital, Bezmialem Vakif University, Istanbul, Turkey.
Hamdard J; Department of Medical Oncology, Medipol University Hospital, Istanbul, Turkey.
Yildirim S; Department of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkey.
Dogan T; Department of Medical Oncology, Pamukkale University Medical Faculty Hospital, Denizli, Turkey.
Isik S; Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Celebi A; Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Gulbagci BB; Department of Medical Oncology, Sakarya University School of Medicine, Sakarya, Turkey.
Paksoy N; Department of Medical Oncology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Dogan M; Department of Medical Oncology, Ankara Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey.
Turk HM; Department of Medical Oncology, Faculty of Medicine Hospital, Bezmialem Vakif University, Istanbul, Turkey.
Bilici A; Department of Medical Oncology, Medipol University Hospital, Istanbul, Turkey.
Tatli AM; Department of Medical Oncology, Akdeniz University Hospital, Antalya, Turkey.
Akbas S; Department of Medical Oncology, Koç University Medical Faculty Hospital, Istanbul, Turkey.
Turan N; Department of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkey.
Hacibekiroglu I; Department of Medical Oncology, Sakarya University School of Medicine, Sakarya, Turkey.
Dogu GG; Department of Medical Oncology, Pamukkale University Medical Faculty Hospital, Denizli, Turkey.
Aydiner A; Department of Medical Oncology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Sumbul AT; Department of Medical Oncology, Baskent University Adana Dr. Turgut Noyan Application and Research Center, Adana, Turkey.
Akyurek S; Department of Radiation Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Yalciner M; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Demirkazik A; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Gursoy P; Department of Medical Oncology, Ege University Medical Faculty Hospital, Izmir, Turkey.
Aykan MB; Department of Medical Oncology, Gulhane Training and Research Hospital, Ankara, Turkey.
Sahin E; Department of Medical Oncology, Kocaeli University Medical Faculty Hospital, Kocaeli, Turkey.
Karadag İ; Department of Medical Oncology, Hittite University Corum Training and Research Hospital, Corum, Turkey.
Kostek O; Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Er MM; Department Of Medical Oncology, Necmettin Erbakan University Meram Medical Faculty Hospital, Konya, Turkey.
Artaç M; Department Of Medical Oncology, Necmettin Erbakan University Meram Medical Faculty Hospital, Konya, Turkey.
Duzkopru Y; Department of Medical Oncology, Ankara Etlik City Hospital, Ankara, Turkey.
Aydin D; Department of Medical Oncology, Kocaeli Derince Training and Research Hospital, Kocaeli, Turkey.
Isik D; Department of Medical Oncology, Kocaeli Medical Park Hospital, Kocaeli, Turkey.
Karakas Y; Department of Medical Oncology, Acıbadem Bodrum Hospital, Mugla, Turkey.
Kilickap S; Department of Medical Oncology, Liv Hospital, Istinye University, Ankara, Turkey.
Erol C; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey.
Demir B; Department of Medical Oncology, Aydin Ataturk State Hospital, Aydin, Turkey.
Civelek B; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara, Turkey.
Ergun Y; Department of Medical Oncology, Batman Training and Research Hospital, Batman, Turkey.
Akinci MB; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey.
Dogan I; Department of Medical Oncology, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
Karadurmus N; Department of Medical Oncology, Gulhane Training and Research Hospital, Ankara, Turkey.
Yumuk PF; Department of Medical Oncology, Koç University Medical Faculty Hospital, Istanbul, Turkey.
Sendur MAN; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 09; Vol. 14 (1), pp. 5820. Date of Electronic Publication: 2024 Mar 09.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Brain Neoplasms*/drug therapy
Brain Neoplasms*/genetics
Central Nervous System Neoplasms*/drug therapy
Humans ; Prognosis ; Retrospective Studies ; ErbB Receptors/genetics ; Treatment Outcome ; Protein Kinase Inhibitors/pharmacology
Czasopismo naukowe
Tytuł:
Survival outcomes following complete mediastinal lymphadenectomy or selective mediastinal lymphadenectomy in patients with stage I-IIIA non-small cell lung cancer: protocol for a systematic review and meta-analysis.
Autorzy:
Xu J; Fuzhou Medical College of Nanchang University, Fuzhou, China.
Lai J; Affiliated Ganzhou Hospital of Nanchang University, Ganzhou, China.
Huang X; Fuzhou Medical College of Nanchang University, Fuzhou, China .
Ren Y; Jiangxi University of Chinese Medicine, Nanchang, China.
Chen Q; Jiangxi University of Chinese Medicine, Nanchang, China.
Li W; Fuzhou Medical College of Nanchang University, Fuzhou, China.
Pokaż więcej
Źródło:
BMJ open [BMJ Open] 2024 Mar 08; Vol. 14 (3), pp. e084520. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/surgery
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/pathology
Humans ; Systematic Reviews as Topic ; Meta-Analysis as Topic ; Lymph Node Excision/adverse effects ; Research Design
Czasopismo naukowe
Tytuł:
Stereotactic ablative brachytherapy versus percutaneous microwave ablation for early-stage non-small cell lung cancer: a multicenter retrospective study.
Autorzy:
Wu C; Department of Interventional Medicine,The Second Hospital of Shandong University, Institute of Tumor Intervention,Cheeloo college of medicine, Shandong University, Jinan City, Shandong Province, China.; Department of Fifth Internal Medicine, People's Hospital of Shizhong District, No.156 Jiefang Road, Zaozhuang City, Shandong Province, China.
Cao B; Department of Oncology, Qufu Hospital of Traditional Chinese Medicine, No.129 Canggeng Road, Qufu City, Shandong Province, China.
He G; Department of Interventional Medicine, Weifang Second People's Hospital, Weifang city, Shandong Province, China.
Li Y; Department of Interventional Medicine,The Second Hospital of Shandong University, Institute of Tumor Intervention,Cheeloo college of medicine, Shandong University, Jinan City, Shandong Province, China.
Wang W; Department of Interventional Medicine,The Second Hospital of Shandong University, Institute of Tumor Intervention,Cheeloo college of medicine, Shandong University, Jinan City, Shandong Province, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 06; Vol. 24 (1), pp. 304. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/radiotherapy
Carcinoma, Non-Small-Cell Lung*/surgery
Lung Neoplasms*/radiotherapy
Lung Neoplasms*/surgery
Humans ; Brachytherapy/adverse effects ; Microwaves/adverse effects ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Head-to-head comparison of F-FDG PET/MRI for lymph node metastasis staging in non-small cell lung cancer: a meta-analysis.
Autorzy:
Zhang M; Lanzhou University, The First Clinical Medical College, Lanzhou, China
Liu Z; Lanzhou University, The First Clinical Medical College, Lanzhou, China
Yuan Y; Lanzhou University, The First Clinical Medical College, Lanzhou, China
Yang W; Lanzhou University, The First Clinical Medical College, Lanzhou, China
Cao X; The First Hospital of Lanzhou University, Department of Thoracic Surgery, Lanzhou, China; The First Hospital of Lanzhou University, Gansu Province International Cooperation Base for Research and Application of Key Technology of Thoracic Surgery, Lanzhou, China
Ma M; The First Hospital of Lanzhou University, Department of Thoracic Surgery, Lanzhou, China; The First Hospital of Lanzhou University, Gansu Province International Cooperation Base for Research and Application of Key Technology of Thoracic Surgery, Lanzhou, China
Han B; The First Hospital of Lanzhou University, Department of Thoracic Surgery, Lanzhou, China; The First Hospital of Lanzhou University, Gansu Province International Cooperation Base for Research and Application of Key Technology of Thoracic Surgery, Lanzhou, China
Pokaż więcej
Źródło:
Diagnostic and interventional radiology (Ankara, Turkey) [Diagn Interv Radiol] 2024 Mar 06; Vol. 30 (2), pp. 99-106. Date of Electronic Publication: 2024 Jan 31.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/diagnostic imaging
Carcinoma, Non-Small-Cell Lung*/pathology
Carcinoma, Non-Small-Cell Lung*/secondary
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/pathology
Humans ; Fluorodeoxyglucose F18 ; Positron Emission Tomography Computed Tomography/methods ; Lymphatic Metastasis/diagnostic imaging ; Radiopharmaceuticals ; Sensitivity and Specificity ; Magnetic Resonance Imaging/methods ; Neoplasm Staging
Czasopismo naukowe
Tytuł:
Immunotherapy Study on Non-small-Cell Lung Cancer (NSCLC) Combined with Cytotoxic T Cells and miRNA34a.
Autorzy:
Pandey R; Department of Medicinal and Applied Chemistry, Kaohsiung Medical University, No. 100 Shih-Chuan first Road, Kaohsiung 80708, Taiwan.
Chiu CC; Department of Biotechnology, Kaohsiung Medical University, No. 100 Shih-Chuan first Road, Kaohsiung 80708, Taiwan.; Department of Medical Research, Kaohsiung Medical University Hospital, No.100 Tzyou first Road, Kaohsiung 80708, Taiwan.
Wang LF; Department of Medicinal and Applied Chemistry, Kaohsiung Medical University, No. 100 Shih-Chuan first Road, Kaohsiung 80708, Taiwan.; Department of Medical Research, Kaohsiung Medical University Hospital, No.100 Tzyou first Road, Kaohsiung 80708, Taiwan.; Institute of Medical Science and Technology, National Sun Yat-Sen University, No.70 Lien-Hai Road, Kaohsiung 804201, Taiwan.
Pokaż więcej
Źródło:
Molecular pharmaceutics [Mol Pharm] 2024 Mar 04; Vol. 21 (3), pp. 1364-1381. Date of Electronic Publication: 2024 Jan 31.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/therapy
Antineoplastic Agents*
MicroRNAs*/genetics
Humans ; T-Lymphocytes, Cytotoxic ; Jurkat Cells ; Immunotherapy/methods
Czasopismo naukowe
Tytuł:
Silencing PinX1 enhances radiosensitivity and antitumor-immunity of radiotherapy in non-small cell lung cancer.
Autorzy:
Qiu J; Division of Life Sciences and Medicine, Department of Radiation Oncology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230001, China.; Core Facility Center for Medical Sciences, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Hefei, 230001, Anhui, China.
Xia Y; Division of Life Sciences and Medicine, Department of Radiation Oncology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230001, China.; Core Facility Center for Medical Sciences, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Hefei, 230001, Anhui, China.
Bao Y; Division of Life Sciences and Medicine, Department of Radiation Oncology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230001, China.; Core Facility Center for Medical Sciences, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Hefei, 230001, Anhui, China.
Cheng J; Division of Life Sciences and Medicine, Department of Radiation Oncology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230001, China.; Core Facility Center for Medical Sciences, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Hefei, 230001, Anhui, China.
Liu L; Division of Life Sciences and Medicine, Department of Radiation Oncology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230001, China.; Core Facility Center for Medical Sciences, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Hefei, 230001, Anhui, China.
Qian D; Division of Life Sciences and Medicine, Department of Radiation Oncology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230001, China. .; Core Facility Center for Medical Sciences, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Hefei, 230001, Anhui, China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Mar 02; Vol. 22 (1), pp. 228. Date of Electronic Publication: 2024 Mar 02.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/radiotherapy
Telomerase*/metabolism
Lung Neoplasms*/genetics
Lung Neoplasms*/radiotherapy
Animals ; Mice ; Humans ; Tumor Suppressor Proteins/genetics ; Cell Cycle Proteins/metabolism ; Cell Line, Tumor ; Radiation Tolerance ; Tumor Microenvironment ; RNA-Binding Proteins
Czasopismo naukowe
Tytuł:
β-Sitosterol attenuates anlotinib resistance in non-small cell lung cancer cells by inhibiting miR-181a-3p/SHQ1 signaling.
Autorzy:
Wang LH; Graduate School of Hunan University of Traditional Chinese Medicine, Changsha, Hunan, P.R. China.; The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, P.R. China.
Sun YH; School of Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, P.R. China.
Liu H; Department of Oncology, The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, P.R. China.
Yang X; Department of Oncology, The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, P.R. China.
Wen Z; Department of Oncology, The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, P.R. China.
Tian XF; College of Integrated Traditional Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, P.R. China.
Pokaż więcej
Źródło:
Chemical biology & drug design [Chem Biol Drug Des] 2024 Mar; Vol. 103 (3), pp. e14493.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Indoles*
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
MicroRNAs*/drug effects
MicroRNAs*/genetics
Quinolines*
Sitosterols*
Humans ; Endoplasmic Reticulum Chaperone BiP ; Intracellular Signaling Peptides and Proteins ; Drug Resistance, Neoplasm/drug effects
Czasopismo naukowe
Tytuł:
Integration of on-treatment modified Glasgow prognostic score (mGPS) to improve imaging-based prediction of outcomes in patients with non-small cell lung cancer on immune checkpoint inhibition.
Autorzy:
Saal J; Medical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn (UKB), Germany; Institute of Experimental Oncology, University Hospital Bonn (UKB), Bonn, Germany; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany. Electronic address: https:_jonas.
Bald T; Institute of Experimental Oncology, University Hospital Bonn (UKB), Bonn, Germany; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany. Electronic address: https://twitter.com/@Doc_Bald.
Eckstein M; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Electronic address: https:.
Ralser DJ; Institute of Experimental Oncology, University Hospital Bonn (UKB), Bonn, Germany; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany; Department of Gynaecology and Gynaecological Oncology, University Hospital Bonn (UKB), Bonn, Germany. Electronic address: https:_ralser.
Brossart P; Medical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn (UKB), Germany; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany.
Ellinger J; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany; Department of Urology and Pediatric Urology, University Hospital Bonn (UKB), Bonn, Germany.
Hölzel M; Institute of Experimental Oncology, University Hospital Bonn (UKB), Bonn, Germany; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany. Electronic address: https:.
Klümper N; Institute of Experimental Oncology, University Hospital Bonn (UKB), Bonn, Germany; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany; Department of Urology and Pediatric Urology, University Hospital Bonn (UKB), Bonn, Germany. Electronic address: https:_kluemper.
Pokaż więcej
Źródło:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Mar; Vol. 189, pp. 107505. Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/diagnostic imaging
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Renal Cell*
Kidney Neoplasms*
Lung Neoplasms*/diagnosis
Lung Neoplasms*/drug therapy
Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Prognosis
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies